Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/35471
Title: Thoracic Society of Australia and New Zealand clinical practice guideline on adult home oxygen therapy.
Austin Authors: McDonald, Christine F ;Serginson, John;AlShareef, Saad;Buchan, Catherine;Davies, Huw;Miller, Belinda R;Munsif, Maitri;Smallwood, Natasha;Troy, Lauren;Khor, Yet Hong
Affiliation: Respiratory and Sleep Medicine
Department of Respiratory Medicine, Sunshine Coast Health, Birtinya, Queensland, Australia.;School of Nursing, Midwifery & Social Work, University of Queensland, St Lucia, Queensland, Australia.
Department of Medicine, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
Institute for Breathing and Sleep
Respiratory and Sleep Services, Flinders Medical Centre, Southern Adelaide Local Health Network, South Australia, Australia.
Department of Respiratory Medicine, Alfred Health, Melbourne, Victoria, Australia.;Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.;Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.;Institute for Academic Medicine, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
Issue Date: Sep-2024
Date: 2024
Publication information: Respirology (Carlton, Vic.) 2024-09; 29(9)
Abstract: This Thoracic Society of Australia and New Zealand Guideline on the provision of home oxygen therapy in adults updates a previous Guideline from 2015. The Guideline is based upon a systematic review and meta-analysis of literature to September 2022 and the strength of recommendations is based on GRADE methodology. Long-term oxygen therapy (LTOT) is recommended for its mortality benefit for patients with COPD and other chronic respiratory diseases who have consistent evidence of significant hypoxaemia at rest (PaO2 ≤ 55 mm Hg or PaO2 ≤59 mm Hg in the presence of hypoxaemic sequalae) while in a stable state. Evidence does not support the use of LTOT for patients with COPD who have moderate hypoxaemia or isolated nocturnal hypoxaemia. In the absence of hypoxaemia, there is no evidence that oxygen provides greater palliation of breathlessness than air. Evidence does not support the use of supplemental oxygen therapy during pulmonary rehabilitation in those with COPD and exertional desaturation but normal resting arterial blood gases. Both positive and negative effects of LTOT have been described, including on quality of life. Education about how and when to use oxygen therapy in order to maximize its benefits, including the use of different delivery devices, expectations and limitations of therapy and information about hazards and risks associated with its use are key when embarking upon this treatment.
URI: https://ahro.austin.org.au/austinjspui/handle/1/35471
DOI: 10.1111/resp.14793
ORCID: 0000-0001-6481-3391
0000-0002-3403-3586
0000-0002-7426-336X
0000-0002-5434-9342
Journal: Respirology (Carlton, Vic.)
Start page: 765
End page: 784
PubMed URL: 39009413
ISSN: 1440-1843
Type: Journal Article
Subjects: clinical respiratory medicine
hypoxaemia
long‐term oxygen therapy
oxygen guideline
oxygen therapy
Oxygen Inhalation Therapy/methods
Oxygen Inhalation Therapy/standards
Home Care Services/standards
Pulmonary Disease, Chronic Obstructive/therapy
Hypoxia/therapy
Appears in Collections:Journal articles

Show full item record

Page view(s)

14
checked on Nov 1, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.